Overall, the SRCIN1 gene is frequently, but not necessarily, co-amplified with ERBB2 in BCs, following chromosomal rearrangements which result in ERBB2 amplification, thus contributing to the biological heterogeneity of this BC subgroup [49]. Here, ERBB2 is linked to breast cancer.